Indaptus Therapeutics, Inc. (INDP) Tops Q2 EPS by 19c
Tweet
Share
E-mailGet Alerts INDP Hot Sheet
Join SI Premium – FREE
Indaptus Therapeutics, Inc. (NASDAQ: INDP) reported Q2 EPS of ($0.39), $0.19 better than the analyst estimate of ($0.58).
For earnings history and earnings-related data on Indaptus Therapeutics, Inc. (INDP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
- Traws Pharma (TRAW) Tops Q2 EPS by 27c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
